POSSIBILITY OF COVID-19 RE-INFECTION & LOSS OF ANTIBODIES

Zebi Fatima

Abstract


Coronavirus is attracting the attention of healthcare professionals and scientists searching for its treatment and vaccine. The study of antibodies is crucial in the development of medicine and the immunization of coronavirus. Antibodies are molecules that are produced by the body or immune system to fight infection. The purpose of this research paper was to determine antibody loss and Covid-19 reinfection.

Antibodies are crucial even if they are produced in small quantities because they can still neutralize the virus. Various researchers show that patients are losing their IgG antibodies. Studies found that about 10% of almost 1,500 patients recovered from Covid-19 produced antibodies out of which 74 lost their antibodies two to three months after recovery.

Studies have revealed that the antibodies level is high during the first three weeks of infection and then declines. Patients with severe illness have more antibody levels than those with mild or asymptomatic patients. It is possible for patients who have recovered from Covid-19 to get infected again; however, researchers should conduct more studies to prove this argument.

The methodology used in this study was the literature search. The researcher obtained data from various literature work and data obtained analyzed qualitatively by identifying and deriving meaning from the literature work. The findings suggest that patients who have recovered from coronavirus are losing their antibodies. The study also found that Covid-19 recovered patients can be affected again, but more research is needed.

The discussion section of the paper discussed the findings by relating them with what other researchers have found. One limitation of the study was the few scientific journals and peer-reviewed articles to support the conclusions. The future scope is the need for further research.

Full Text:

PDF

References


Zhu, N., Zhang, D., Wang, W., and Li, X.

A novel coronavirus from patients with pneumonia in China

The New England Journal of Medicine (2020)

DOI:10.1056/NEJMoa2001017

National Health Institute

Potent antibodies found in people recovered from COVID-19

National Institute of Health Research Matters (30 June 2020)

DOI: 10.1016/j.cellimm.2020.104114

Vabret, N., Britton,G.J., Gruber, C., Hedge, S., et al.

Immunology of COVID-19: Current State of the Science

Elsevier Public Health Emergency Collection (vol. 52, no. 6, pp. 910-941, 16 June 2020)

DOI:10.1016/j.immuni.2020.05.002

World Health Organization

Immunity passports" in the context of COVID-19

Scientific Brief, (24 April 2020)

https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid 19?gclid=CjwKCAjwgdX4BRB_EiwAg8O8Hbkd2BAdfFyxJPVWAL5EiICMiEJxCmt_YXSBquc-hgG-_0fB1_G6HBoCMEAQAvD_BwE

Robbiani, D.F., Gaebler, C., & Nussenzweig, M.C.

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Nature, (18 June 2020)

https://doi.org/10.1038/s41586-020-2456-9

Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.-S.

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Clin. Infect. Dis, (2020)

DOI: 10.1093/cid/ciaa248

Malgaco,J.G., Azamor, T., & Bom, A.P.D.A

Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?

Cell Immunology, (2020)

DOI: 10.1016/j.cellimm.2020.104114

Wu F., Wang A., Liu M., Wang Q., Chen J., Xia S., Ling Y., Zhang Y., Xun J., Lu L., Jiang S., Lu H., Wen Y., & Huang, J.

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Infectious Diseases, (2020)

DOI:10.1101/2020.03.30.20047365

Callaway, E., Ledford, H., & Mallapaty, S.

Six months of coronavirus: the mysteries scientists are still racing to solve

Nature Research Journal, (03 July 2020)

https://www.nature.com/articles/d41586-020-01989-z

Centers for Disease Control and Prevention

Coronavirus disease 2019: Test forpast infection

(30 June 2020)

https://www.cdc.gov/coronavirus/2019-ncov/testing/serology-overview.html

Zhang W, Du R, Li B, & Zheng X

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Emerging Microbes Infection, vol. 9, no. 1, (2020) pp. 386-389

DOI:10.1080/22221751.2020.1729071

H. Snyder

Literature review as a research methodology: an overview and guidelines

Journal of Business Research, 104 (2019) PP. 333-339

1016/j.jbusres.2019.07.039


Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2020 INTERNATIONAL EDUCATION AND RESEARCH JOURNAL